Healthspan

Antique clock
#Age-related diseases (ARDs) #Ageing #Epigenetics #Healthspan #Multiomics #Rejuvenation therapies

Turning back the epigenetic clock: Can we reverse ageing?

In this article, based on a session at Life Sciences Baltics 2025, Diana Turner reviews the latest research into epigenetics and rejuvenation.  An epigenetic clock is a biomarker of ageing that can be used to estimate ‘biological age’. The method relies on the modifications to DNA that… Read More

#Exclusive Content

#Artificial intelligence (AI) #Healthspan #Longevity #Partnership

M42 partners with Juvenescence on longevity drug discovery

Global health company M42 has announced a strategic investment and partnership with longevity biotech Juvenescence.   The partnership will focus on identifying and developing a pipeline of AI-enabled therapeutics to extend healthy lifespan and advance the treatment of life-threatening diseases. The partnership will leverage M42’s expertise in genomics,… Read More

#Business & Investment #News

Ageing hands
#Ageing #Healthspan #Junevity #Seed funding #siRNA #Transcriptomics

Biotech raises $10m to address ageing at a cellular level

Junevity, a biotechnology company hoping to extend lifespan and healthspan by resetting cell damage from age-related diseases, has announced $10 million in seed funding led by Goldcrest Capital and Godfrey Capital.  The Junevity RESET platform is based on exclusively licensed research by co-founder Dr Janine Sengstack at… Read More

#Business & Investment #News

Laboratory mouse
#Ageing #Antibody #Duke-NUS Medical School #Healthspan #Imperial College London #Medical Research Council Laboratory of Medical Science #Mouse models

Anti-IL-11 drug extends lifespan by over 20% in mice

Scientists have discovered that ‘switching off’ protein interleukin 11 (IL-11) can significantly increase the healthy lifespan of mice by almost 25%. The scientists at the Medical Research Council Laboratory of Medical Science (MRC LMS) and Imperial College London, working with colleagues at Duke-NUS Medical School in… Read More

#Editor's Choice #News

Senior couple jogging
#Age-related diseases (ARDs) #clock.bio #Healthspan #iPSC #Regenerative Medicine

clock.bio begins mission to extend health span by 20 years

Longevity biotech clock.bio has launched with $4 million in funding to develop regenerative medicines to prevent and treat age-related diseases. The company says its immediate objective is to decode all rejuvenation programmes present in human cells, to build an atlas of disease and rejuvenation targets for… Read More

#Business & Investment #News

Autophagy
#ALS #Autophagy #Healthspan #Neurodegenerative disorders #Parkinson's #Turning Science into Business

Turning Science into Business: Inducing autophagy to treat disease

DDW’s Diana Spencer speaks to Peter Hamley, Chief Scientific Officer of Samsara Therapeutics, to understand the role autophagy plays in neurodegenerative diseases and how boosting this process could increase healthspan. DS: Samsara’s autophagy inducing candidate SAM001 will be the first agent of its class to enter clinical trials. Read More

#Exclusive Content